Literature DB >> 2676347

Inspiratory work of breathing on flow-by and demand-flow continuous positive airway pressure.

C S Sassoon1, A E Giron, E A Ely, R W Light.   

Abstract

Continuous positive airway pressure (CPAP) breathing can be delivered using the demand-flow (DF) or continuous-flow (CF) system. A modified CF system, the flow-by (FB) system, operates with preset base-flow (BF) values between 5 and 20 L/min. The DF depends on changes in pressure for opening the pneumatic valve of the system (pressure sensitivity). In contrast, the FB depends on changes in flow (flow sensitivity). In six healthy male subjects, we determined the mechanical inspiratory work of breathing (WI, J/L) and the inspiratory work rate (J/min) on the DF and the FB systems at a BF of 5 and 20 L/min, at CPAP levels of 0, 5, and 10 cm H2O. In comparison to DF, on the FB system both WI and inspiratory work rate were significantly less at a CPAP of 10 cm H2O (p less than .01). This was most likely due to the smaller drop in airway pressure at the onset of inspiration with the FB system. Varying the BF values in the FB system had no effect on WI or inspiratory work rate.

Entities:  

Mesh:

Year:  1989        PMID: 2676347     DOI: 10.1097/00003246-198911000-00004

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  10 in total

1.  Inspiratory work imposed by continuous positive airway pressure (CPAP) machines: the effect of CPAP level and endotracheal tube size.

Authors:  J L Moran; S Homan; M O'Fathartaigh; M Jackson; P Leppard
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

2.  Effects of different triggering systems and external PEEP on trigger capability of the ventilator.

Authors:  Y A Konyukov; N Kuwayama; T Fukuoka; T Takahashi; T Mayumi; T Hotta; J Takezawa
Journal:  Intensive Care Med       Date:  1996-04       Impact factor: 17.440

Review 3.  Characteristics of the ventilator pressure- and flow-trigger variables.

Authors:  C S Sassoon; S E Gruer
Journal:  Intensive Care Med       Date:  1995-02       Impact factor: 17.440

4.  Health economic modeling of the potential cost saving effects of Neurally Adjusted Ventilator Assist.

Authors:  Jonas Hjelmgren; Sara Bruce Wirta; Pernilla Huetson; Karl-Johan Myrén; Sylvia Göthberg
Journal:  Ther Adv Respir Dis       Date:  2015-09-30       Impact factor: 4.031

5.  Physiological effects of flow and pressure triggering during non-invasive mechanical ventilation in patients with chronic obstructive pulmonary disease.

Authors:  S Nava; N Ambrosino; C Bruschi; M Confalonieri; C Rampulla
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

6.  Pressure support ventilation via face mask in acute respiratory failure in hypercapnic COPD patients.

Authors:  R Fernandez; L Blanch; J Valles; F Baigorri; A Artigas
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

7.  Work of breathing, inspiratory flow response, and expiratory resistance during continuous positive airway pressure with the ventilators EVITA-2, EVITA-4 and SV 300.

Authors:  E Calzia; K H Lindner; W Stahl; A Martin; P Radermacher; M Georgieff
Journal:  Intensive Care Med       Date:  1998-09       Impact factor: 17.440

8.  Flow-triggering reduces inspiratory effort during weaning from mechanical ventilation.

Authors:  G Polese; A Massara; R Poggi; R Brandolese; G Brandi; A Rossi
Journal:  Intensive Care Med       Date:  1995-08       Impact factor: 17.440

9.  Inspiratory effort and measurement of dynamic intrinsic PEEP in COPD patients: effects of ventilator triggering systems.

Authors:  V M Ranieri; L Mascia; V Petruzzelli; F Bruno; A Brienza; R Giuliani
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

10.  Effect of low-level PEEP on inspiratory work of breathing in intubated patients, both with healthy lungs and with COPD.

Authors:  M Sydow; W Golisch; H Buscher; J Zinserling; T A Crozier; H Burchardi
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.